Free form individualized lenses present opportunities, challenges

Article

The current system of eyeglass lens manufacturing, in which semi-finished "blanks" are delivered and finished in on-site laboratories, will give way to a system in which individually designed lenses are crafted for each patient.

Dr. Sheedy predicted that this switch to "free form" manufacturing will take place over the next 5 to 10 years. The ability to create optics uniquely designed based upon specific characteristics of the patient's eyes and face will be both a boon and a challenge, as very precise measurements will be required to ensure proper performance. Dr. Sheedy is director of optometry research at Pacific University College of Optometry, Forest Grove, OR.

"Properly measuring and fitting the eyewear to the patient is already important for all prescriptions in terms of making sure that the lenses are properly centered in front of the eyes, making sure that the pantoscopic tilt is correct, and making sure that the sitting heights are appropriate," Dr. Sheedy said. "But all of this becomes even more critical for the individualized lenses that use the free form manufacturing technique."

The optical aspects that are individualized by free form lenses include the distance correction for single-vision lenses and multifocals, the near design for progressive addition lenses (PALs), and some other features related to how the lenses are used and the frame characteristics. Free form manufacturing enables an individualized atoric design for each eye, Dr. Sheedy said.

For single-vision lenses and the distance characteristics of PALs, free form manufacturing allows extremely fine aspheric and atoric curvatures to be selected for the particular prescription of the patient. This eliminates the visual compromises that may be caused by using semi-finished lenses that offer only a limited series of standardized base curves. The aspheric and atoric design feature is incorporated into the PAL individualized design. The lens design can also optimize the near vision of PALs.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.